PRIME® Continuing Medical EducationThe Future of NSCLC Care: Leveraging Biomarker Testing in the Management of Early-Stage, Resectable DiseaseJoin us for an engaging discussion on integrating biomarker-directed therapies into early-stage, resectable NSCLC care. We will delve into the latest clinical evidence, as well as real-world data and insights gleaned from community oncology care teams across the US who participated in a quali
